Complimentary Virtual CE Breast Cancer Program
Posted about 16 hours ago by Laura Hart
Join two nationally renowned breast oncology experts in this dynamic webinar focused on improving outcomes for patients with HR+/HER2- advanced breast cancer, with a special emphasis on targeting the PI3K/AKT/PTEN pathway.
This session will explore the latest clinical data on PI3K and AKT inhibitors, and provide practical strategies for applying this knowledge in real-world patient care.
Through case studies, live polling, and a Q&A session, the faculty will guide you through treatment options, patient selection, and best practices for managing adverse events associated with targeted therapies.
When: Thursday, May 1, 2025 at 2:00pm ET - 3:00pm ET
Credits Offered
This event offers 1.0 contact hours to attendees